These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24111669)

  • 1. Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study.
    Farmer S; Horváth-Puhó E; Vestergaard H; Hermann AP; Frederiksen H
    Br J Haematol; 2013 Dec; 163(5):603-10. PubMed ID: 24111669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study.
    Frederiksen H; Farkas DK; Christiansen CF; Hasselbalch HC; Sørensen HT
    Blood; 2011 Dec; 118(25):6515-20. PubMed ID: 22039256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.
    Malak S; Labopin M; Saint-Martin C; Bellanne-Chantelot C; Najman A;
    Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):170-6. PubMed ID: 22818858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.
    Kannegaard PN; van der Mark S; Eiken P; Abrahamsen B
    Age Ageing; 2010 Mar; 39(2):203-9. PubMed ID: 20075035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of fracture in incident multiple sclerosis patients: the Danish National Health Registers.
    Bazelier MT; Bentzen J; Vestergaard P; Stenager E; Leufkens HG; van Staa TP; de Vries F
    Mult Scler; 2012 Nov; 18(11):1609-16. PubMed ID: 22472998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
    Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
    Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic myeloproliferative neoplasms in Singapore: A population-based study on incidence, trends, and survival from 1968 to 2017.
    Htun HL; Lian W; Wong J; Tan EJ; Foo LL; Ong KH; Lim WY
    Cancer Epidemiol; 2022 Aug; 79():102175. PubMed ID: 35569302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Why do we close our eyes while the world is falling? A study on proximal femur osteoporotic fractures in a Portuguese population].
    Cruz M
    Acta Reumatol Port; 2009; 34(2B):370-7. PubMed ID: 19727048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.
    Hodsman AB; Leslie WD; Tsang JF; Gamble GD
    Arch Intern Med; 2008 Nov; 168(20):2261-7. PubMed ID: 19001204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of osteoporosis].
    Bonjour JP; Burckhardt P; Dambacher M; Kraenzlin ME; Wimpfheimer C
    Schweiz Med Wochenschr; 1997 Apr; 127(16):659-67. PubMed ID: 9198892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
    J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study.
    Frederiksen H; Farkas DK; Christiansen CF; Larsen TS; Hasselbalch HC; Stentoft J; Sørensen HT
    Lancet Haematol; 2015 Jul; 2(7):e289-96. PubMed ID: 26688384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
    Smith MD; Ross W; Ahern MJ
    J Rheumatol; 2001 Nov; 28(11):2504-8. PubMed ID: 11708425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
    Bucalossi A; Marotta G; Bigazzi C; Galieni P; Dispensa E
    Am J Hematol; 1996 May; 52(1):14-20. PubMed ID: 8638606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
    Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2068-73. PubMed ID: 19531676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals.
    Sode BF; Dahl M; Nordestgaard BG
    Eur Heart J; 2011 Oct; 32(19):2365-75. PubMed ID: 21875856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falls and comorbidity: the pathway to fractures.
    Jørgensen TS; Hansen AH; Sahlberg M; Gislason GH; Torp-Pedersen C; Andersson C; Holm E
    Scand J Public Health; 2014 May; 42(3):287-94. PubMed ID: 24434943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.